An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19

Reuben McGregor(University of Auckland), Behdad Afzali(National Institute of Diabetes and Digestive and Kidney Diseases)
bioRxiv (Cold Spring Harbor Laboratory)
July 19, 2020
Cited by 32


Related Papers